- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
ARQ Wealth Advisors LLC Buys 4,385 Shares of Johnson & Johnson
The firm's new stake in the healthcare giant is valued at $813,000.
Mar. 19, 2026 at 7:24am
Got story updates? Submit your updates here. ›
ARQ Wealth Advisors LLC purchased a new stake of 4,385 shares in Johnson & Johnson (NYSE:JNJ) during the third quarter, according to a recent SEC filing. The new position is valued at approximately $813,000. The move comes as other major institutional investors, including Wellington Management Group, Bank of New York Mellon, and Legal & General Group, have also increased their holdings in Johnson & Johnson in recent quarters.
Why it matters
Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a portfolio spanning pharmaceuticals, medical devices, and consumer health products. As a bellwether stock, changes in institutional ownership of JNJ shares can provide insights into broader investor sentiment and expectations for the company and the healthcare sector.
The details
According to the 13F filing, ARQ Wealth Advisors LLC established the new 4,385-share position in Johnson & Johnson during the third quarter of 2025. The firm's investment in JNJ is valued at approximately $813,000 based on the stock's price at the end of the quarter. The filing shows that other major institutional investors have also been active in trading JNJ shares, with firms like Wellington Management, Bank of New York Mellon, and Legal & General Group all increasing their stakes in the company during the same period.
- ARQ Wealth Advisors LLC purchased the new Johnson & Johnson shares in the third quarter of 2025.
The players
ARQ Wealth Advisors LLC
An investment management firm that purchased a new 4,385-share stake in Johnson & Johnson.
Johnson & Johnson
A multinational healthcare company that develops, manufactures, and markets pharmaceutical, medical device, and consumer health products.
Wellington Management Group LLP
A global investment management firm that increased its holdings in Johnson & Johnson by 956,239 shares in the third quarter.
Bank of New York Mellon Corp
A financial services company that raised its Johnson & Johnson stake by 835,146 shares in the third quarter.
Legal & General Group Plc
A multinational financial services company that boosted its Johnson & Johnson holdings by 532,790 shares in the third quarter.
The takeaway
The new stake taken by ARQ Wealth Advisors in Johnson & Johnson, along with increased holdings by other major institutional investors, suggests continued confidence in the healthcare giant's long-term prospects despite near-term market volatility. As a diversified leader in pharmaceuticals, medical devices, and consumer health, Johnson & Johnson remains an attractive investment for institutional and retail investors alike.
